Logo image of CLVT

CLARIVATE PLC (CLVT) Stock Fundamental Analysis

NYSE:CLVT - New York Stock Exchange, Inc. - JE00BJJN4441 - Common Stock - Currency: USD

4.08  -0.11 (-2.63%)

After market: 4.15 +0.07 (+1.72%)

Fundamental Rating

3

CLVT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 82 industry peers in the Professional Services industry. CLVT may be in some trouble as it scores bad on both profitability and health. CLVT is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CLVT was profitable.
CLVT had a positive operating cash flow in the past year.
In the past 5 years CLVT always reported negative net income.
CLVT had a positive operating cash flow in each of the past 5 years.
CLVT Yearly Net Income VS EBIT VS OCF VS FCFCLVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

With a Return On Assets value of -5.90%, CLVT is not doing good in the industry: 73.17% of the companies in the same industry are doing better.
The Return On Equity of CLVT (-13.49%) is worse than 74.39% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.81%, CLVT is doing worse than 63.41% of the companies in the same industry.
CLVT had an Average Return On Invested Capital over the past 3 years of 1.87%. This is significantly below the industry average of 12.96%.
Industry RankSector Rank
ROA -5.9%
ROE -13.49%
ROIC 1.81%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
CLVT Yearly ROA, ROE, ROICCLVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

CLVT has a Operating Margin of 9.03%. This is in the better half of the industry: CLVT outperforms 68.29% of its industry peers.
In the last couple of years the Operating Margin of CLVT has grown nicely.
CLVT has a Gross Margin of 66.06%. This is in the better half of the industry: CLVT outperforms 78.05% of its industry peers.
CLVT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 9.03%
PM (TTM) N/A
GM 66.06%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
CLVT Yearly Profit, Operating, Gross MarginsCLVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

1

2. Health

2.1 Basic Checks

CLVT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CLVT has more shares outstanding
The number of shares outstanding for CLVT has been increased compared to 5 years ago.
The debt/assets ratio for CLVT is higher compared to a year ago.
CLVT Yearly Shares OutstandingCLVT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CLVT Yearly Total Debt VS Total AssetsCLVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

CLVT has an Altman-Z score of -0.37. This is a bad value and indicates that CLVT is not financially healthy and even has some risk of bankruptcy.
CLVT has a worse Altman-Z score (-0.37) than 79.27% of its industry peers.
CLVT has a debt to FCF ratio of 13.96. This is a negative value and a sign of low solvency as CLVT would need 13.96 years to pay back of all of its debts.
CLVT's Debt to FCF ratio of 13.96 is in line compared to the rest of the industry. CLVT outperforms 42.68% of its industry peers.
A Debt/Equity ratio of 0.90 indicates that CLVT is somewhat dependend on debt financing.
CLVT has a Debt to Equity ratio of 0.90. This is in the lower half of the industry: CLVT underperforms 69.51% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.96
Altman-Z -0.37
ROIC/WACC0.25
WACC7.34%
CLVT Yearly LT Debt VS Equity VS FCFCLVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CLVT has a Current Ratio of 0.88. This is a bad value and indicates that CLVT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLVT's Current ratio of 0.88 is on the low side compared to the rest of the industry. CLVT is outperformed by 79.27% of its industry peers.
CLVT has a Quick Ratio of 0.88. This is a bad value and indicates that CLVT is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.88, CLVT is doing worse than 78.05% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.88
CLVT Yearly Current Assets VS Current LiabilitesCLVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

CLVT shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -6.33%.
Measured over the past 5 years, CLVT shows a small growth in Earnings Per Share. The EPS has been growing by 1.87% on average per year.
Looking at the last year, CLVT shows a decrease in Revenue. The Revenue has decreased by -3.50% in the last year.
CLVT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 21.28% yearly.
EPS 1Y (TTM)-6.33%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.43%

3.2 Future

CLVT is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.22% yearly.
Based on estimates for the next years, CLVT will show a small growth in Revenue. The Revenue will grow by 1.89% on average per year.
EPS Next Y-9.64%
EPS Next 2Y-1.62%
EPS Next 3Y2.44%
EPS Next 5Y3.22%
Revenue Next Year-7.6%
Revenue Next 2Y-3.68%
Revenue Next 3Y-1.45%
Revenue Next 5Y1.89%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLVT Yearly Revenue VS EstimatesCLVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
CLVT Yearly EPS VS EstimatesCLVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.2 0.4 0.6 0.8 1

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 5.51, the valuation of CLVT can be described as very cheap.
Based on the Price/Earnings ratio, CLVT is valued cheaper than 91.46% of the companies in the same industry.
When comparing the Price/Earnings ratio of CLVT to the average of the S&P500 Index (25.82), we can say CLVT is valued rather cheaply.
The Price/Forward Earnings ratio is 5.70, which indicates a rather cheap valuation of CLVT.
CLVT's Price/Forward Earnings ratio is rather cheap when compared to the industry. CLVT is cheaper than 95.12% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CLVT to the average of the S&P500 Index (21.76), we can say CLVT is valued rather cheaply.
Industry RankSector Rank
PE 5.51
Fwd PE 5.7
CLVT Price Earnings VS Forward Price EarningsCLVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

84.15% of the companies in the same industry are more expensive than CLVT, based on the Enterprise Value to EBITDA ratio.
92.68% of the companies in the same industry are more expensive than CLVT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.6
EV/EBITDA 7.33
CLVT Per share dataCLVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.62%
EPS Next 3Y2.44%

0

5. Dividend

5.1 Amount

CLVT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CLARIVATE PLC

NYSE:CLVT (5/23/2025, 9:23:31 PM)

After market: 4.15 +0.07 (+1.72%)

4.08

-0.11 (-2.63%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)04-29 2025-04-29/bmo
Earnings (Next)08-04 2025-08-04/bmo
Inst Owners62.29%
Inst Owner ChangeN/A
Ins Owners0.91%
Ins Owner Change13.4%
Market Cap2.79B
Analysts77.33
Price Target5.39 (32.11%)
Short Float %13.17%
Short Ratio7.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP-2.77%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.96%
Min EPS beat(2)1.61%
Max EPS beat(2)18.32%
EPS beat(4)4
Avg EPS beat(4)7.04%
Min EPS beat(4)0.21%
Max EPS beat(4)18.32%
EPS beat(8)7
Avg EPS beat(8)6.48%
EPS beat(12)11
Avg EPS beat(12)8.87%
EPS beat(16)14
Avg EPS beat(16)8.11%
Revenue beat(2)1
Avg Revenue beat(2)0.26%
Min Revenue beat(2)-1.53%
Max Revenue beat(2)2.04%
Revenue beat(4)1
Avg Revenue beat(4)-1.63%
Min Revenue beat(4)-4.81%
Max Revenue beat(4)2.04%
Revenue beat(8)2
Avg Revenue beat(8)-1.38%
Revenue beat(12)3
Avg Revenue beat(12)-1.33%
Revenue beat(16)4
Avg Revenue beat(16)-1.47%
PT rev (1m)-11.05%
PT rev (3m)-16.17%
EPS NQ rev (1m)0.18%
EPS NQ rev (3m)-10.9%
EPS NY rev (1m)2.4%
EPS NY rev (3m)-8.95%
Revenue NQ rev (1m)-0.95%
Revenue NQ rev (3m)-8.74%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)-6.96%
Valuation
Industry RankSector Rank
PE 5.51
Fwd PE 5.7
P/S 1.1
P/FCF 8.6
P/OCF 4.34
P/B 0.55
P/tB N/A
EV/EBITDA 7.33
EPS(TTM)0.74
EY18.14%
EPS(NY)0.72
Fwd EY17.56%
FCF(TTM)0.47
FCFY11.63%
OCF(TTM)0.94
OCFY23.02%
SpS3.7
BVpS7.36
TBVpS-7.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.9%
ROE -13.49%
ROCE 2.29%
ROIC 1.81%
ROICexc 1.88%
ROICexgc N/A
OM 9.03%
PM (TTM) N/A
GM 66.06%
FCFM 12.81%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
ROICexc(3y)1.93%
ROICexc(5y)1.38%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.36%
ROCE(5y)1.69%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y62.12%
ROICexc growth 5Y45.61%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.96
Debt/EBITDA 4.7
Cap/Depr 43.33%
Cap/Sales 12.56%
Interest Coverage 250
Cash Conversion 66.74%
Profit Quality N/A
Current Ratio 0.88
Quick Ratio 0.88
Altman-Z -0.37
F-Score6
WACC7.34%
ROIC/WACC0.25
Cap/Depr(3y)37.07%
Cap/Depr(5y)34.15%
Cap/Sales(3y)10.18%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6.33%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-9.64%
EPS Next 2Y-1.62%
EPS Next 3Y2.44%
EPS Next 5Y3.22%
Revenue 1Y (TTM)-3.5%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.43%
Revenue Next Year-7.6%
Revenue Next 2Y-3.68%
Revenue Next 3Y-1.45%
Revenue Next 5Y1.89%
EBIT growth 1Y-13.36%
EBIT growth 3Y32.53%
EBIT growth 5Y83.55%
EBIT Next Year9366.24%
EBIT Next 3Y361.89%
EBIT Next 5Y157.15%
FCF growth 1Y-23.35%
FCF growth 3Y16.61%
FCF growth 5Y48.48%
OCF growth 1Y-4.15%
OCF growth 3Y25.93%
OCF growth 5Y40.62%